Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cara Therapeutics Inc. buy marge

Cara Therapeutics Inc.
Start price
€6.27
31.10.16 / 50%
Target price
€20.75
17.04.17
Performance (%)
146.30%
End price
€15.45
17.04.17
Summary
This prediction ended on 17.04.17 with a price of €15.45. With a performance of 146.30% the BUY prediction by marge was a big success. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Cara Therapeutics Inc. - - - -
iShares Core DAX® -1,59 % 5,03 % 6,33 % 64,06 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 % 86,92 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 % 77,87 %
iShares S&P 500 -3,23 % 0,47 % 20,45 % 68,19 %

Comments by marge for this prediction

In the thread Cara Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 146.30%
Target price 20.746
Change
Ends at 17.04.17

marge stimmt der Buy-Einschätzung von datca zu

marge stimmt am 31.10.2016 der Buy-Einschätzung von datca mit dem Kursziel 12$ zu.
Überschrift: Cara seems to offer a very positive risk/reward profile at current trading levels.

marge 
0
Report Share
31.10.16
Prediction Buy
Perf. (%) 146.30%
Target price 20.746
Change
Ends at 17.04.17

(Vom Mitglied beendet)

marge 
0
Report Share
17.04.17

Stopped prediction by marge for Cara Therapeutics Inc.

buy
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.22
18.04.17
€17.14
21.06.17
13.75%
21.06.17

marge 
14.08.19 50%